Publication | Closed Access
High-dose taxol (HDT) with G-CSF in patients with advanced breast cancer (ABC) refractory to anthracycline (ANT) therapy
10
Citations
0
References
1993
Year
Advanced Breast CancerBreast OncologyHigh-dose TaxolMedicinePharmacologyBreast CancerAnti-cancer AgentCancer TreatmentOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!